Establishment Labs announces $50M registered direct offering and FY2024 revenue guidance of $165-168M

ESTABLISHMENT LABS HOLDINGS INC.

Offering of 765,696 common shares at $45.71/share and pre-funded warrants for 328,161 shares; total gross proceeds ~$50M.
Additional 76,569 shares and 32,815 warrant shares issuable if average closing price ≤$45.71 between Jan-Aug 2025.
FY2024 revenue expected $165-168M; FY2025 non-U.S. revenue mid-single digit growth; U.S. revenue >$35M.
Credit agreement amended: Tranche D commitment termination extended to Dec 31, 2025; milestone set at $195M trailing 12-month gross sales including $30M U.S. for Motiva.
Net proceeds to be used for sales/marketing, R&D, working capital, and capex.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.